SCHEMBL8612934

SCHEMBL8612934

O=c1[nH]c2cc(C(F)(F)F)ccc2n(C2CCCCC2)c1=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.59
SMN1; SMN2 Q16637 2/20 0.59
OPRL1 P41146 7/20 0.55
OPRM1 P35372 6/20 0.55
OPRD1 P41143 5/20 0.55
OPRK1 P41145 5/20 0.55
SIRT2 Q8IXJ6 1/20 0.45
CYP2C9 P11712 2/20 0.45
CYP2C19 P33261 2/20 0.45
MEN1 O00255 1/20 0.44
CYP1A2 P05177 1/20 0.44
HSP90AA1 P07900 1/20 0.44
CYP3A4 P08684 1/20 0.44
MAPT P10636 1/20 0.44
TSHR P16473 1/20 0.44
NFKB1 P19838 1/20 0.44
BLM P54132 1/20 0.44
PMP22 Q01453 1/20 0.44
KMT2A Q03164 1/20 0.44
KCNMA1 Q12791 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1272249 0.94 OPRL1 (0.65) ALDH1A1SMN1; SMN2OPRL1OPRM1OPRD1
SCHEMBL7191677 0.87 ALDH1A1 (0.61) ALDH1A1SMN1; SMN2OPRL1OPRM1OPRK1
SCHEMBL9395676 0.83 OPRL1 (0.71) OPRL1OPRM1OPRD1OPRK1SIRT2
SCHEMBL7480936 0.80 OPRL1 (0.59) OPRL1OPRM1OPRD1OPRK1SIRT2
SCHEMBL8676782 0.78 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2OPRL1OPRM1OPRD1
SCHEMBL8611338 0.78 OPRL1 (0.52) ALDH1A1SMN1; SMN2OPRL1OPRM1OPRD1
SCHEMBL9395659 0.77 OPRL1 (0.55) OPRL1OPRM1OPRD1OPRK1SIRT2
SCHEMBL30910142 0.76 OPRL1 (0.86) OPRL1OPRM1OPRD1OPRK1
SCHEMBL26092381 0.76 OPRL1 (0.86) OPRL1OPRM1OPRD1OPRK1
SCHEMBL9395620 0.76 SIRT2 (0.77) ALDH1A1SMN1; SMN2OPRL1OPRM1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4948794-A NEUROLEPTIC AGENTS A/S FERROSAN (DK) 1990-08-14 US claimed
US-5852017-A 2,3(1H,4H)-quinoxalinediones BASF AKTIENGESELLSCHAFT (DE) 1998-12-22 US disclosed
EP-0572852-B1 Quinoxalin-2,3(1H,4H)-diones used as medicine BASF AG (DE) 1998-10-21 EP disclosed
US-5714489-A 2,3(1H,4H)quinoxalinedione BASF AKTIENGESELLSCHAFT (DE) 1998-02-03 US disclosed
EP-0315959-B1 Quinoxaline compounds and their preparation and use NOVO NORDISK AS (DK) 1994-03-02 EP disclosed
EP-0572852-A1 Quinoxalin-2,3(1H,4H)-diones used as medicine BASF Aktiengesellschaft (DE) 1993-12-08 EP disclosed
US-5026704-A Neuroleptic agent, quisqualate-antagonist NOVO NORDISK A/S (DK) 1991-06-25 US disclosed
US-4948794-A NEUROLEPTIC AGENTS A/S FERROSAN (DK) 1990-08-14 US disclosed
EP-0315959-A2 Quinoxaline compounds and their preparation and use NOVO NORDISK A/S (DK) 1989-05-17 EP disclosed